Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells

Department of Nutrition and Exercise Sciences, Oregon State University, Corvallis, OR 97331, USA.
Cancer Letters (Impact Factor: 5.02). 03/2007; 246(1-2):201-9. DOI: 10.1016/j.canlet.2006.02.015
Source: PubMed

ABSTRACT There is increasing evidence that certain natural compounds found in plants may be useful as cancer chemopreventive or chemotherapeutic agents. Limited in vitro studies indicate that several prenylated flavonoids present in the hop plant (Humulus lupulus) possess anticarcinogenic properties. The purpose of this study was to investigate the anti-tumorigenic effects of xanthohumol (XN), the major prenylflavonoid in hops, on prostate cancer and benign prostate hyperplasia. BPH-1 and PC3 cell lines were used in our study to represent both non-tumorigenic hyperplasia and malignant prostate cancer. In both BPH-1 and PC3 cells, XN and its oxidation product, XAL, decreased cell viability in a dose dependent manner (2.5-20 microM) as determined by MTT assay and caused an increase in the formation of early and late apoptotic cells as determined by Annexin V staining and multicaspase assays. XN and its oxygenated derivative also induced cell cycle changes in both cells lines, seen in an elevated sub G1 peak at 48h treatment. Western blot analysis was performed to confirm the activation of proapoptotic proteins, Bax and p53. XN and its derivative caused decreased activation of NFkappaB. This work suggests that XN and its oxidation product, XAL, may be potentially useful as a chemopreventive agent during prostate hyperplasia and prostate carcinogenesis, acting via induction of apoptosis and down-regulation of NFkappaB activation in BPH-1 cells.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The long term health consequences of alcoholic beverage drinking are related primarily to the unfavourable influence of ethyl alcohol on the organism, which contributes to an increased risk of the development of various diseases. It is obvious that the excessive drinking of alcoholic beverages, including beer, has a negative impact on health, but it must be emphasised that compounds of hops are characterised by a multidirectional influence, including a health-related properties. Hop is a valuable source of polyphenolic compounds, which were classified into several structural groups characterised by various biological activities. Studies concerning bioactive substances present in beer, indicate that certain flavonoid compounds derived from hop are characterised by antioxidant, anti-inflammatory, anti-cancer, antiangiogenic or estrogenic properties. Due to these properties, it is important to determine the potential applicability of selected polyphenol compounds. Examination of their effects on the human body, as well as understanding the mechanisms of this influence will allow the development of methods for using these compounds in natural adjuvant treatment. The aim of the study was to characterise the main flavonoids found in beer - xanthohumol, isoxanthohumol and 8-prenylnaringenin and specify their multidirectional impact on the human body based on the literature.
    Alkoholizm i narkomania 09/2014; 27(3):273-281. DOI:10.1016/S0867-4361(14)70020-3
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Female hop cones are used extensively in the brewing industry, but there is now increasing interest in possible uses of hops for non-brewing purposes, especially in the pharmaceutical industry. Among pharmaceutically important compounds from hops are flavonoids, having proven anticarcinogenic, antioxidant, antimicrobial, anti-inflammatory and estrogenic effects. In this review we aim to present current knowledge on the biotransformation of flavonoids from hop cones with respect to products, catalysis and conversion. A list of microbial enzymatic reactions associated with gastrointestinal microbiota is presented. A comparative analysis of the biological activities of hop flavonoids and their biotransformation products is described, indicating where further research has potential for applications in the pharmaceutical industry. Copyright © 2015. Published by Elsevier Inc.
    Biotechnology Advances 02/2015; DOI:10.1016/j.biotechadv.2015.02.009 · 8.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The female inflorescences of hops (Humulus lupulus L.), a well-known bittering agent used in the brewing industry, have long been used in traditional medicines. Xanthohumol (XN) is one of the bioactive substances contributing to its medical applications. Among foodstuffs XN is found primarily in beer and its natural occurrence is surveyed. In recent years, XN has received much attention for its biological effects. The present review describes the pharmacological aspects of XN and summarizes the most interesting findings obtained in the preclinical research related to this compound, including the pharmacological activity, the pharmacokinetics, and the safety of XN. Furthermore, the potential use of XN as a food additive considering its many positive biological effects is discussed.
    Molecules 01/2015; 20(1):754-779. DOI:10.3390/molecules20010754 · 2.10 Impact Factor